Hung P.-F.Chang Y.-C.Hong T.-M.PAN-CHYR YANGSZU-HUA PAN2020-12-022020-12-0220161556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044324322&doi=10.1016%2fS1556-0864%2816%2930191-5&partnerID=40&md5=7a6fe994af3d0aba07b832b1d853a9fbhttps://scholars.lib.ntu.edu.tw/handle/123456789/523478[SDGs]SDG3antimetastatic agent; aptamer; B12 antagonist aptamer; B8 antagonist aptamer; collapsin response mediator protein; LCRMP 1 antagonist aptamer; Myc protein; unclassified drug; Article; disease severity; drug effect; drug identification; drug mechanism; EC50; human; immunoprecipitation; in vitro study; metastasis inhibition; non small cell lung cancer; overall survival; priority journal; protein binding; protein expression; protein function; systematic evolution of ligands by exponential enrichment aptamer techniquejournal article10.1016/S1556-0864(16)30191-52-s2.0-85044324322